Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Schubert NA"'
Autor:
Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Chen CY; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Rodríguez A; Hoffman-La Roche, Basel, Switzerland., Koster J; Department of Oncogenomics, Amsterdam University Medical Center, Amsterdam, the Netherlands., Dowless M; Eli Lilly and Company, Indianapolis, IN, USA., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital, Heidelberg, Germany., Shields DJ; Pfizer Centers for Therapeutic Innovation, Pfizer Inc., New York, NY, USA., Stancato LF; Eli Lilly and Company, Indianapolis, IN, USA., Vassal G; Institute Gustave Roussy, Université Paris Saclay, Villejuif, France., Caron HN; Hoffman-La Roche, Basel, Switzerland., van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Henssen AG; Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, And German Cancer Research Center (DKFZ), Heidelberg, Germany; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, Netherlands. Electronic address: j.j.molenaar@prinsesmaximacentrum.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jul; Vol. 170, pp. 196-208. Date of Electronic Publication: 2022 Jun 04.
Autor:
Keller KM; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands., Krausert S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Gopisetty A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Luedtke D; Eli Lilly and Company, Indianapolis, IN, USA., Koster J; Department of Oncogenomics, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Schubert NA; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands., Rodríguez A; Hoffman-La Roche, Basel, Switzerland., van Hooff SR; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands., Stichel D; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Dolman MEM; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, NSW Australia., Vassal G; Department of Clinical Research, Gustave Roussy, Villejuif, France., Pfister SM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany., Caron HN; Hoffman-La Roche, Basel, Switzerland., Stancato LF; Eli Lilly and Company, Indianapolis, IN, USA., Molenaar JJ; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands., Jäger N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Kool M; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany. Electronic address: m.kool@kitz-heidelberg.de.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Feb; Vol. 162, pp. 107-117. Date of Electronic Publication: 2021 Dec 25.
Autor:
Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bate-Eya LT; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Alles LK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lee JY; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia., Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jonus HC; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia., Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lelieveld D; Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands., Egan DA; Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands., Kerstjens M; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Stam RW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Koster J; Department of Oncogenomics, Amsterdam UMC, location AMC, Amsterdam, the Netherlands., Goldsmith KC; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. memdolman@gmail.com.; Children's Cancer Institute, Lowy Cancer Research Center, UNSW Sydney, Sydney, NSW, Australia.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Jun; Vol. 20 (6), pp. 1161-1172. Date of Electronic Publication: 2021 Apr 13.
Autor:
Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Oirschot S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Alles LK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Nulle ME; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.j.molenaar@prinsesmaximacentrum.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jan; Vol. 142, pp. 1-9. Date of Electronic Publication: 2020 Nov 13.
Autor:
Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lowery CD; Eli Lilly and Company, Indianapolis, IN, USA., Bergthold G; Hoffman-La Roche, Basel, Switzerland., Koster J; Department of Oncogenomics, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Eleveld TF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Rodríguez A; Hoffman-La Roche, Basel, Switzerland., Jones DTW; Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Vassal G; Department of Clinical Research, Gustave Roussy, Villejuif, France., Stancato LF; Eli Lilly and Company, Indianapolis, IN, USA., Pfister SM; Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg University Hospital, Heidelberg, Germany., Caron HN; Hoffman-La Roche, Basel, Switzerland., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.j.molenaar@prinsesmaximacentrum.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 May; Vol. 130, pp. 168-181. Date of Electronic Publication: 2020 Mar 27.
Autor:
Schmidt C; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Schubert NA; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Brabetz S; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Mack N; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Schwalm B; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Chan JA; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Selt F; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Herold-Mende C; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Witt O; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Milde T; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Pfister SM; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Korshunov A; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Kool M; Division of Pediatric Neurooncology, German Cancer Research Center, Heidelberg, Germany; Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute and Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Heidelberg, Germany; Department of Pediatric Oncology, Hematology and Immunology, Section of Pediatric Brain Tumors, University Hospital Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, Clinical Trial Center, Heidelberg, Germany; Division of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2017 Nov 29; Vol. 19 (12), pp. 1607-1617.
Autor:
van Lith SA; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., Navis AC; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., Lenting K; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., Verrijp K; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., Schepens JT; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, The Netherlands., Hendriks WJ; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, The Netherlands., Schubert NA; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., Venselaar H; Centre for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, The Netherlands., Wevers RA; Translational Metabolic Laboratory, Department Laboratory Medicine, Radboudumc, Nijmegen, The Netherlands., van Rooij A; Translational Metabolic Laboratory, Department Laboratory Medicine, Radboudumc, Nijmegen, The Netherlands., Wesseling P; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Molenaar RJ; Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands., van Noorden CJ; Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands., Pusch S; Clinical Cooperation Unit Neuropathology, German Cancer Center (DKFZ), Heidelberg, Germany., Tops B; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., Leenders WP; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.
Publikováno v:
Scientific reports [Sci Rep] 2016 Jul 27; Vol. 6, pp. 30486. Date of Electronic Publication: 2016 Jul 27.